Literature DB >> 8333948

Reduction in growth temperature minimizes instability of large plasmids containing HIV-1 proviral genomes.

A Joshi1, K T Jeang.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8333948

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  8 in total

1.  Construction and characterization of a minimized version of the HIV-1 pNL4-3 plasmid and its application for pseudotyping HIV-1 vectors.

Authors:  María Luisa Abad; Tomás Verdura; Alicia Vela; María José Iglesias; Dolores Gutiérrez; Manuel Veiga; Antonio Aguilera; Benito J Regueiro
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

2.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.

Authors:  C Neuveut; K T Jeang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.

Authors:  Robert A Smith; Dana N Raugi; Vincent H Wu; Sally S Leong; Kate M Parker; Mariah K Oakes; Papa Salif Sow; Selly Ba; Moussa Seydi; Geoffrey S Gottlieb
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Expression and functional characterization of the cardiac muscle ryanodine receptor Ca(2+) release channel in Chinese hamster ovary cells.

Authors:  M B Bhat; S M Hayek; J Zhao; W Zang; H Takeshima; W G Wier; J Ma
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

5.  Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.

Authors:  R F Chun; O J Semmes; C Neuveut; K T Jeang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.

Authors:  Robert A Smith; Vincent H Wu; Jennifer Song; Dana N Raugi; Khardiata Diallo Mbaye; Moussa Seydi; Geoffrey S Gottlieb
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759

8.  Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.

Authors:  L M Huang; A Joshi; R Willey; J Orenstein; K T Jeang
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.